US2014220128A1PendingUtilityA1

Solid Dosage Form

50
Assignee: ARROW INT LTDPriority: Aug 24, 2006Filed: Apr 14, 2014Published: Aug 7, 2014
Est. expiryAug 24, 2026(~0.1 yrs left)· nominal 20-yr term from priority
A61P 19/10A61K 31/663A61K 9/2077A61J 3/10A61K 9/5015A61K 9/2081A61K 9/5026A61K 9/501A61K 9/5031A61K 31/675A61K 9/2054C07F 9/3865
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A solid dosage form comprises coated particles of bisphosphonate or a pharmaceutically acceptable analogue or derivative thereof.

Claims

exact text as granted — not AI-modified
1 - 42 . (canceled) 
     
     
         43 . A method for formulating a solid dosage form, comprising:
 (i) combining particles of bisphosphonate or a pharmaceutically acceptable analogue or derivative thereof with a coating solution or suspension consisting essentially of a coating and a solvent, wherein the coating contains a pharmaceutically acceptable, water soluble sugar and the amount of coating is from 10% to 70% by weight of the uncoated particles;   (ii) drying the solution or suspension to form coated particles of bisphosphonate;   (iii) mixing the coated particles of (ii) with one or more excipients; and   (iv) forming the coated particles and one or more excipients into a solid dosage form.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.